# New Pre-Eclampsia clinical trials: 156 posted since Nov 2024

Updated November 3, 2026.

156 clinical studies in Pre-Eclampsia were first posted on ClinicalTrials.gov from November 12, 2024 to November 3, 2026; 8 have an industry sponsor and 119 are recruiting or about to. The newest, NCT07912866, was posted on November 3, 2026: Efficacy Of Supplemental L-Arginine in Preventing Preeclampsia in Pregnant Women (Quaid-e-Azam Medical College).

## The full list

New Pre-Eclampsia clinical trials: 156 rows for $7.80, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Enrollment, Enrollment type, Location countries, Central contact, Contact phone, Contact email, Last update posted, Read on, Source. The new rows each week by email, about 7 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/condition/pre-eclampsia

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

- New trials: 156
- Industry sponsored: 8
- Recruiting or not yet: 119
- Latest posted: November 3, 2026

## Newest trials

The newest 100 of 156, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 3, 2026 | NCT07912866 | Efficacy Of Supplemental L-Arginine in Preventing Preeclampsia in Pregnant Women | Quaid-e-Azam Medical College | Not applicable | Completed | Pre-eclampsia | 108 | Pakistan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07912866) |
| October 26, 2026 | NCT07894705 | Blood Pressure Goal in Preterm Preeclampsia | Ohio State University | Observational | Not yet recruiting | Hypertensive Disorder of Pregnancy, Preeclampsia | 68 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07894705) |
| October 14, 2026 | NCT07874191 | Retinal and Choroidal Microcirculation in Preeclampsia: An OCTA Study | Muğla Sıtkı Koçman University | Observational | Recruiting | Preeclampsia (PE), Hypertension ,Pregnancy, Retinal Microvascular Changes, Hypertensive Disorders of Pregnancy | 90 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07874191) |
| October 8, 2026 | NCT07866196 | Prevalence of Asymptomatic Bacteriuria Among Pregnant Women With Pre-eclampsia in Women Health Hospital Assiut University | Assiut University | Observational | Not yet recruiting | Pre-Eclampsia, Asymptomatic Bacteriuria | 129 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07866196) |
| October 6, 2026 | NCT07861685 | Role of Postpartum Furosemide in Recovery of Patients With Severe Preeclampsia | Lady Reading Hospital, Pakistan | Not applicable | Recruiting | Severe Preeclampsia | 434 | Pakistan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07861685) |
| October 1, 2026 | NCT07852585 | Comparison of Pregnancy Outcomes in Primigravida Receiving Low-Dose Aspirin for the Prevention of Preeclampsia. | Muhammad Aamir Latif | Not applicable | Completed | Preeclampsia | 160 | Pakistan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07852585) |
| September 28, 2026 | NCT07844876 | Enhancing Prediction of Adverse Pregnancy Outcomes in Africa Through Partnerships and Innovation | Makerere University | Observational | Recruiting | Fetal Growth Restriction (FGR), Preterm Birth, Still Births, Abruptio Placentae, Rupture of Membranes; Premature... | 4,000 | Uganda | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07844876) |
| September 25, 2026 | NCT07842783 | Norepinephrine Infusion vs Bolus vs Ephedrine for Blood Pressure Stability During Cesarean Delivery in Women With Preeclampsia | Benha University | Not applicable | Completed | Preeclampsia, Cesarean Birth, Hypotension During Surgery | 84 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07842783) |
| September 25, 2026 | NCT07842341 | MH-Rx Study (Baby on Board: Check-in on You, Your Medication, & Your Blood Pressure) | Texas Southern University | Not applicable | Recruiting | Hypertensive Disorders of Pregnancy, Chronic Hypertension in Pregnancy, Gestational Hypertension | 158 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07842341) |
| September 25, 2026 | NCT07841795 | Ophthalmic Artery Doppler in the Puerperium After Hypertensive Disorders of Pregnancy (OPHELIA-PP) | University of Roma La Sapienza | Observational | Not yet recruiting | Hypertensive Disorders of Pregnancy, Pre-eclampsia, Postpartum Hypertension, Puerperal Disorders, Maternal Haemodynamics | 366 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07841795) |
| September 25, 2026 | NCT07841197 | Cohort Study on the Levels of Placental Growth Factor and Nucleosomes in Early Pregnancy and Adverse Pregnancy Outcomes | Second Affiliated Hospital of Wenzhou Medical University | Observational | Not yet recruiting | Preeclampsia, Premature Birth, Fetal Growth Restriction, Recurrent Miscarriage | 900 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07841197) |
| September 17, 2026 | NCT07825649 | Modelization of Early Endometrial-trophoblast Molecular Interaction | Centre Hospitalier Intercommunal Creteil | Not applicable | Not yet recruiting | Infertility, Eclampsia Preeclampsia | 500 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07825649) |
| September 9, 2026 | NCT07810439 | PROTECT-Africa: Biomarker Validation for Preeclampsia Triage | Africa Clinical Research Network (ACRN) | Observational | Recruiting | Hypertension, Pregnancy-Induced, HELLP Syndrome, Eclampsia, Fetal Growth Retardation, Pre-eclampsia | 1,106 | Zimbabwe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07810439) |
| September 8, 2026 | NCT07807098 | Exploring the Effect of Discharge Education, Blood Pressure Cuffs, and Postpartum Bracelets to Improve Health Among Newly Diagnosed... | Memorial Hermann Health System | Not applicable | Not yet recruiting | Preeclampsia, Gestational Hypertension, Postpartum | 40 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07807098) |
| August 31, 2026 | NCT07793760 | Dexamethasone Versus Ondansetron for Preventing Post-Spinal Hypotension in Preeclampsia | Assiut University | Phase 4 | Not yet recruiting | Preeclampsia, Spinal Anesthesia-Induced Hypotension, Cesarean Section | 110 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07793760) |
| August 25, 2026 | NCT07786246 | Internal Jugular Vein Collapsibility Index for Volume Status Assessment in Preeclampsia in Correlation With Normotensive Parturients | Tanta University | Observational | Recruiting | Pre-Eclampsia, Preeclampsia | 80 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07786246) |
| August 21, 2026 | NCT07779057 | Comparison of High- Versus Low-Dose Aspirin for Pregnancy Outcomes in Women at High Risk of Preeclampsia | Medicare Hospital (Pvt) Limited | Phase 4 | Recruiting | Preeclampsia | 60 | Pakistan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07779057) |
| August 21, 2026 | NCT07778966 | Community Health Worker Support to Lower Blood Pressure After a Pregnancy With High Blood Pressure | University of Alabama at Birmingham | Not applicable | Recruiting | Pregnancy-Associated Hypertension, Gestational Hypertension, Preeclampsia, Eclampsia, HELLP Syndrome, Postpartum... | 174 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07778966) |
| August 7, 2026 | NCT07752056 | Low-Sodium Diet for Postpartum Blood Pressure Control | Women and Infants Hospital of Rhode Island | Not applicable | Not yet recruiting | Hypertensive Disorder of Pregnancy, Pre-Eclampsia, Severe, Pre-Eclampsia; Mild, Postpartum | 110 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07752056) |
| August 5, 2026 | NCT07746271 | Gestational Hypertension and Preeclampsia Blood Pressure (BP) Treatment Goals Less Than 140/90 vs. Less Than 160/110 mmHg: The GOALPOST... | The George Washington University Biostatistics Center | Phase 3 | Not yet recruiting | Hypertension in Pregnancy, Obstetrical Complications | 4,120 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07746271) |
| August 4, 2026 | NCT07745036 | Role of Progesterone Membrane Receptors in the Pathogenesis of Preeclampsia | Samsun University | Observational | Recruiting | Preeclampsia, Preeclampsia Complications | 90 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07745036) |
| July 31, 2026 | NCT07738562 | Dipyridamole for Early-Onset Preeclampsia: A Pilot Study of Feasibility, Pharmacokinetics, and Biological Effects | Hadassah Medical Organization | Phase 1/2 | Not yet recruiting | Preeclampsia (PE), Hypertension ,Pregnancy | 15 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07738562) |
| July 27, 2026 | NCT07728656 | Endothelial Extracellular Vesicles as Biomarkers of Endothelial Activation in Pregnant Women With Hypertensive Disorders of Pregnancy | Josip Juraj Strossmayer University of Osijek | Observational | Recruiting | Hypertensive Disorder of Pregnancy, Gestational Hypertension, Preeclampsia | 80 | Croatia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07728656) |
| July 21, 2026 | NCT07717931 | Vitamin D Therapy to Prevent Recurrent Preeclampsia in High-Risk Pregnancies | CMH Multan Institute of Medical Sciences | Phase 4 | Completed | Preeclampsia | 146 | Pakistan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07717931) |
| July 20, 2026 | NCT07715669 | Antidepressant Therapy for Improved Blood Vessel Health After Preeclampsia | Anna Stanhewicz, PhD | Early phase 1 | Recruiting | Preeclampsia, Endothelial Function | 40 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07715669) |
| July 14, 2026 | NCT07703826 | Identification of Genes of Interest for Severe Forms of Preeclampsia | University Hospital, Strasbourg, France | Observational | Not yet recruiting | Preeclampsia, Severe Preeclampsia | 100 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07703826) |
| July 10, 2026 | NCT07695909 | Gestational Changes in Hemodynamics and Respiratory Mechanics in Association With Pre-Eclampsia | Icahn School of Medicine at Mount Sinai | Observational | Not yet recruiting | Pre-eclampsia, Pregnancy, Post Partum | 100 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07695909) |
| June 25, 2026 | NCT07669935 | Advancing Stillbirth Prevention Through Innovative Risk Evaluation (ASPIRE) Clinical Study | Medicines360 | Observational | Recruiting | GDM, Preterm Preeclampsia, Preeclampsia, Fetal Growth Restriction (FGR), Pregnancy Complications | 5,500 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07669935) |
| June 24, 2026 | NCT07665853 | Optimizing the Use of Aspirin for the Prevention of Preeclampsia | Hospital Universitari Vall d'Hebron Research Institute | Phase 3 | Not yet recruiting | Preeclampsia | 15,160 | Austria, Bulgaria, Ghana, Senegal, Spain, The Gambia, United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07665853) |
| June 24, 2026 | NCT07665112 | Algorithm-Based Timing of Delivery Using the sFlt-1/PlGF Ratio in Early-Onset Severe Preeclampsia. (MAP 2 Study : Management Based on... | Hospital Clinic of Barcelona | Not applicable | Not yet recruiting | Severe Preeclampsia | 386 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07665112) |
| June 22, 2026 | NCT07659821 | Harvesting Health: Advancing Nutrition and Wellness for Moms and Babies | Texas A&M University | Not applicable | Recruiting | Pregnant Women With Singleton Pregnancies | 800 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07659821) |
| June 18, 2026 | NCT07656532 | Polyphenol Intake, Mediterranean Diet Adherence, and Oxidative Stress in Pregnancy | University of Salamanca | Not applicable | Not yet recruiting | Pregnancy, Gestational Diabetes Mellitus (GDM), Preeclampsia, Hypertension, Pregnancy-Induced, Oxidative Stress... | 60 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07656532) |
| June 15, 2026 | NCT07648706 | Vitamin D3 Supplementation Regimens and Preeclampsia Risk | Sana'a University | Not applicable | Recruiting | Preeclampsia | 268 | Yemen | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07648706) |
| June 15, 2026 | NCT07648251 | Furosemide vs Placebo in Severe Preeclampsia Postpartum | Universidad Nacional Autonoma de Honduras | Phase 2 | Not yet recruiting | Severe Preeclampsia | 186 | Honduras | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07648251) |
| June 12, 2026 | NCT07646561 | Transcranial Doppler in Preeclampsia and Its Complications. | University Tunis El Manar | Observational | Completed | Pre Eclampsia | 100 | Tunisia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07646561) |
| June 11, 2026 | NCT07643116 | Impact of Concept Mapping in Case-Based Learning Among Medical Students | University Tunis El Manar | Not applicable | Completed | Medical Education, Clinical Reasoning, Case-based Learning, Concept Mapping Versus Interviews | 26 | Tunisia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07643116) |
| June 5, 2026 | NCT07630623 | Effects of Progressive Muscle Relaxation Exercise and Finger Grip Exercise on Stress, Anxiety, Fatigue, Sleep Quality, and Physiological... | Hatice Nur Nefes Pala | Not applicable | Enrolling by invitation | Pregnancy, Preeclampsia | 90 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07630623) |
| June 4, 2026 | NCT07625501 | CercaTest™ Red Urine Test for Predicting Preeclampsia | Chinese University of Hong Kong | Observational | Active not recruiting | Preeclampsia | 1,000 | Hong Kong | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07625501) |
| June 2, 2026 | NCT07621133 | Cost-Effectiveness of an mHealth Application in Pregnancy Care | Principal Engineering s.r.o. | Not applicable | Completed | Hypertensive Disorders of Pregnancy (HDP), Maternal Health Care, Mobile Health Technology (mHealth), Preeclampsia (PE)... | 166 | Czechia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07621133) |
| May 29, 2026 | NCT07614893 | Clinician Notification to Increase Aspirin Prophylaxis for Preeclampsia Prevention | Massachusetts General Hospital | Not applicable | Not yet recruiting | Preeclampsia, Hypertensive Disorders of Pregnancy (HDP), Pregnancy Complications, Aspirin Prophylaxis | 1,000 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07614893) |
| May 20, 2026 | NCT07599579 | Mobile Health Program for Post-Preeclampsia Hypertension | University of Pittsburgh | Not applicable | Recruiting | Hypertension (HTN), Preeclampsia, Hypertensive Disorders of Pregnancy (HDP) | 50 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07599579) |
| May 19, 2026 | NCT07595016 | Clinical Validation of the Blood Pressure Measuring Device Withings BPM Pro 2 in Pregnancy and Pre-Eclampsia | Withings | Not applicable | Recruiting | Hypertension, Pre-eclampsia | 45 | Armenia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07595016) |
| May 7, 2026 | NCT07572656 | Comparison of Intravenous Labetalol and Intravenous Hydralazine in Severe Preeclampsia | Muhammad Aamir Latif | Not applicable | Completed | Preeclampsia | 132 | Pakistan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07572656) |
| May 5, 2026 | NCT07567430 | Digital Game and Simulation in Midwifery Education | Medipol University | Not applicable | Completed | Healthy Adult | 120 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07567430) |
| May 4, 2026 | NCT07565727 | Cardiometabolic Disease and Substrate Metabolism | University of Tennessee Graduate School of Medicine | Observational | Recruiting | Preeclampsia, Gestational Diabetes Mellitus (GDM), Preeclampsia (PE), Preeclampsia (PE) Risk, Gestational Diabetes... | 50 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07565727) |
| May 4, 2026 | NCT07564856 | Climate-Safe Pregnancy Intervention for Women With Preeclclampsia | Benha University | Not applicable | Completed | Preeclampsia, Pregnancy Complications, Climate Change and Maternal Health | 104 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07564856) |
| April 30, 2026 | NCT07559773 | The ROOT Study: Scaling the 'Standard of Care Plus' Obstetric Nutrition Model to Optimize Maternal and Infant Health | GrowBaby Life Project | Not applicable | Not yet recruiting | Preterm Birth, Preeclampsia, Gestational Diabetes Mellitus (GDM), Small for Gestational Age (SGA), Large for... | 500 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07559773) |
| April 23, 2026 | NCT07547046 | Factors Associated With Blood Pressure Control Failure to Intravenous Labetalol in Severe Preeclampsia | Assistance Publique - Hôpitaux de Paris | Observational | Not yet recruiting | Severe Preeclampsia | 350 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07547046) |
| April 7, 2026 | NCT07514130 | Assessment of Volume Status in Preeclampsia Post- SpinalAnasthesia:Utilizing Ultrasound " Evaluation of Lung and Inferior Vena Cava" | Menoufia University | Early phase 1 | Active not recruiting | Preeclampsia | 62 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07514130) |
| April 7, 2026 | NCT07513558 | Preeclampsia: Origin, Characteristics and Effects on Mother and Baby | Medical University of Graz | Observational | Recruiting | Preeclampsia (PE), Pregnancy | 250 | Austria | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07513558) |
| April 3, 2026 | NCT07510568 | Vitamin D Supplementation Among Pregnant Women in Uganda for the Prevention of Hypertensive Disorders in Pregnancy, and Other Adverse... | St Mary's Hospital, Lacor | Phase 4 | Not yet recruiting | Preeclampsia, Eclampsia, HELLP Syndrome | 1,980 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07510568) |
| March 27, 2026 | NCT07496788 | Investigation of the Role of Internal Jugular Vein Collapsibility Index in Predicting Spinal Anesthesia-Induced Hypotension in Preeclamptic... | Ankara City Hospital Bilkent | Observational | Not yet recruiting | Spinal Anesthesia-Induced Hypotension, Preeclampsia, Cesarean Section | 96 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07496788) |
| March 20, 2026 | NCT07485140 | Prevention of Preeclampsia in Denmark: A National Implementation Study | Copenhagen University Hospital at Herlev | Observational | Recruiting | Preeclampsia (PE) | 80,000 | Denmark | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07485140) |
| March 18, 2026 | NCT07479329 | Estimated Risk of Preeclampsia in the First Trimester and Its Association With Subclinical Atherosclerosis and Cardiovascular Risk in Women... | Institut d'Investigacions Biomèdiques August Pi i Sunyer | Observational | Recruiting | Type 1 Diabetes, Preeclampsia, Preeclampsia (PE) Risk | 1,300 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07479329) |
| March 17, 2026 | NCT07478055 | Biomarkers in Management of Post Partum Preeclampsia | Alexander Harrison | Phase 4 | Not yet recruiting | Preeclampsia Severe, Preeclampsia Postpartum | 100 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07478055) |
| March 13, 2026 | NCT07470320 | Placental Biology in Health and Disease | University of Oxford | Observational | Recruiting | Pre-eclampsia, Gestational Diabetes Mellitus (GDM), Fetal Growth Restriction (FGR), Pregnancy Induced Hypertension... | 1,000 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07470320) |
| March 12, 2026 | NCT07467226 | MATERNAL SERUM CADHERİN-6 AS A PREDİCTOR OF PREECLAMPSİA | Samsun University | Observational | Completed | Preeclampsia, Pregnancy Biomarker, Cadherin-6 | 150 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07467226) |
| March 11, 2026 | NCT07463898 | A Study to Find and Confirm Blood-based Markers (Called Proteins) That May Show Early Heart Changes in Women With Preeclampsia, Even Before... | Washington University School of Medicine | Observational | Recruiting | Cardiovascular Biomarkers, Preeclampsia (PE) Risk, Preeclampsia (PE) | 172 | Nigeria | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07463898) |
| March 9, 2026 | NCT07458997 | Usability Evaluation of Gen AI-based Nutrition Chatbot for Pregnant Women | Hong Kong Metropolitan University | Not applicable | Not yet recruiting | Diabetes, Gestational, Pre-eclampsia, AI Chatbot for Prenatal Nutrition Guidance | 100 | Hong Kong | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07458997) |
| March 4, 2026 | NCT07448597 | Progesterone Preeclampsia | Medical University of South Carolina | Phase 4 | Recruiting | Preeclampsia, Hypertensive Disorder of Pregnancy | 642 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07448597) |
| March 2, 2026 | NCT07443345 | Incidence of Postoperative Diaphragmatic Dysfunction in Pregnant Women With Preeclampsia | Cairo University | Observational | Recruiting | Preecalmpsia | 52 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07443345) |
| February 24, 2026 | NCT07430254 | Finger Plethysmography to Predict Fluid Responsiveness in Healthy Pregnancy and Severe Preeclampsia | Stanford University | Observational | Not yet recruiting | Pre-Eclampsia, Severe, Pregnancy | 88 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07430254) |
| February 20, 2026 | NCT07423741 | Ultrasonographical Assessment of Airway Indices in Pregnancy | South Valley University | Observational | Recruiting | Airway Assessment | 180 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07423741) |
| February 17, 2026 | NCT07411937 | Kynurenine Concentrations During Pregnancy in Women With or Without Chronic Kidney Disease - A Prospective Multicenter Study | CHU de Reims | Not applicable | Not yet recruiting | Chronic Kidney Diseases, Pregnancy, Preeclampsia | 204 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07411937) |
| February 3, 2026 | NCT07384936 | Topefilgrastim Injection in the Treatment of High-Risk Pregnant Patients With Preeclampsia | Fang Wang | Not applicable | Not yet recruiting | Preeclampsia | 100 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07384936) |
| January 28, 2026 | NCT07373756 | Randomized Controlled Study to Compare Efficacy of Aspirin 75mg and 150mg In the Prevention of Preeclampsia In High Risk Pregnant Women | Dr. Sunita Pun | Phase 4 | Not yet recruiting | Pregnancy Induced Hypertension (PIH) | 86 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07373756) |
| January 23, 2026 | NCT07361679 | LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia Prevention | Alexandra Hospital, Athens, Greece | Phase 4 | Recruiting | Preeclampsia Severe, Toxemia Of Pregnancy, Preeclampsia, Pregnancy Complications, Hypertension, Pregnancy-Induced... | 100 | Greece | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07361679) |
| January 21, 2026 | NCT07356817 | Cardiovascular Risk Assessment in Young Women After Index Pregnancy With and Without Placental Complications | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Observational | Recruiting | Cardiovascular (CV) Risk, Preeclampsia (PE), Fetal Weight | 1,260 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07356817) |
| January 21, 2026 | NCT07356518 | Telehealth and Remote Blood Pressure | Wake Forest University Health Sciences | Not applicable | Recruiting | Hypertension, Hypertension in Pregnancy | 60 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07356518) |
| January 16, 2026 | NCT07349277 | Evaluation of sFlt-1/PlGF Ratio ,OPG and sEng as Predictive Biomarkers in the Diagnosis and Treatment Evaluation of Preeclampsia | Ammar Jassim Abed | Observational | Recruiting | Preeclampsia, Gestational Hypertension, Hypertensive Disorders of Pregnancy | 120 | Iraq | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07349277) |
| January 16, 2026 | NCT07345845 | MR and Inflammation After Preeclampsia | Anna Stanhewicz, PhD | Early phase 1 | Withdrawn | Preeclampsia, Preeclampsia Postpartum | 0 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07345845) |
| January 8, 2026 | NCT07327255 | Pharmacokinetic Study to Evaluate Safety and Tolerability of EG-101 in Healthy Female Volunteers as a Safety Lead-In for Dosing in Pregnant... | Evergreen Therapeutics, Inc. | Phase 1 | Not yet recruiting | Pre-eclampsia | 24 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07327255) |
| January 5, 2026 | NCT07316140 | fullPIERS Model in the Prediction of Adverse Maternal Outcomes in Preeclampsia | Sohag University | Observational | Not yet recruiting | Preeclampsia, Fullpairs | 50 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07316140) |
| December 23, 2025 | NCT07299773 | Evaluation of Patients With Hypertensive Disorders of Pregnancy: An Ambispective Observational Study | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Not yet recruiting | Preeclampsia, Preeclampsia (PE), Hypertensive Disorder of Pregnancy | 120 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07299773) |
| December 19, 2025 | NCT07293728 | A Randomized Feasibility Trial Comparing Drospirenone and Norethindrone for Postpartum Hypertension Management in Preeclampsia | Oregon Health and Science University | Phase 4 | Not yet recruiting | Hypertension, Preeclampsia | 50 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07293728) |
| December 17, 2025 | NCT07288801 | Vitamin D for Preventing Recurrent Preeclampsia in Pregnant Women | Nishtar Medical University | Phase 4 | Recruiting | Pre-eclampsia, Pregnancy, Vitamin D | 146 | Pakistan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07288801) |
| December 15, 2025 | NCT07282171 | A Study to Investigate the Safety, Pharmacodynamic and Pharmacokinetic Characteristics of CBP-4888 in Hospitalized Participants With... | Comanche Biopharma | Phase 1 | Recruiting | sFlt1 Mediated Preterm Preeclampsia, Preeclampsia, Preterm Preeclampsia | 60 | Australia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07282171) |
| December 4, 2025 | NCT07265336 | Excess Base Comparison Between Pregnant Subjects With Severe Preeclampsia vs. Normotensive Pregnant Women | Saint Thomas Hospital, Panama | Not applicable | Completed | Preeclampsia, Severe Preeclampsia | 100 | Panama | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07265336) |
| December 4, 2025 | NCT07263490 | PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients) | Copenhagen University Hospital, Hvidovre | Observational | Recruiting | Pre-eclampsia, Oocyte Donation, Pre-Eclampsia; Complicating Pregnancy, Pre-Eclampsia; Mild, Pre-Eclampsia, Severe... | 462 | Denmark | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07263490) |
| December 3, 2025 | NCT07261956 | Lung Ultrasound for the Detection of Volume Overload in Patients With Severe Preeclampsia | Saint Thomas Hospital, Panama | Not applicable | Recruiting | Pulmonary Edema - Acute, Preeclampsia | 202 | Panama | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07261956) |
| December 1, 2025 | NCT07255677 | Effect of Stretching Exercises Versus Aerobic Exercises on Preeclampsia | Cairo University | Not applicable | Not yet recruiting | Preeclampsia | 60 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07255677) |
| November 24, 2025 | NCT07245056 | Fetal Fornix and Hippocampus in Pregnant Women With Early-Onset Preeclampsia | Ankara Etlik City Hospital | Not applicable | Completed | Pre-Eclampsia, Hippocampus | 84 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07245056) |
| November 20, 2025 | NCT07238400 | Cardiac Effects of Mineralocorticoid Receptor Antagonism After Hypertensive Disorders of Pregnancy | Massachusetts General Hospital | Phase 2 | Recruiting | Hypertension | 90 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07238400) |
| November 14, 2025 | NCT07229261 | MitoQ to Improve Vascular Funciton in Preeclampsia | Medical College of Wisconsin | Not applicable | Recruiting | Preeclampsia, Pregnancy | 80 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07229261) |
| October 30, 2025 | NCT07222852 | Cardiovascular Protection After Preeclampsia With Enalapril | Women and Infants Hospital of Rhode Island | Phase 3 | Recruiting | Preeclampsia, Hypertensive Disorder of Pregnancy, Hypertension, Gestational Hypertension, Gestational Hypertension... | 60 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07222852) |
| October 24, 2025 | NCT07220902 | Levetiracetam Compared to Magnesium Sulfate for Prevention of Eclamptic Seizure | Nebraska Methodist Health System | Phase 3 | Not yet recruiting | Severe Preeclampsia, Eclampsia Preeclampsia | 1,240 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07220902) |
| October 20, 2025 | NCT07218237 | Mindfulness and Wearable Biosensors to Prevent Hypertensive Disorders of Pregnancy | Medical College of Wisconsin | Not applicable | Recruiting | Preeclampsia | 90 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07218237) |
| October 6, 2025 | NCT07209254 | Randomized Controlled Trial of Two Mobile Health Strategies to Manage Postpartum Hypertension | Jennifer Lewey, MD, MPH | Not applicable | Recruiting | Hypertension, Pregnancy Induced | 770 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07209254) |
| September 30, 2025 | NCT07199283 | The PreEclampsia Postpartum Prevention Trial | Karolinska Institutet | Not applicable | Recruiting | Preeclampsia, Postpartum Period, Hypertension, Cardiovascular Diseases, Overweight, Obesity | 356 | Sweden | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07199283) |
| September 26, 2025 | NCT07193680 | NOPE37: Angiogenic Factors for Managing Term Preeclampsia | Hospital Universitari Vall d'Hebron Research Institute | Not applicable | Recruiting | Preeclampsia | 750 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07193680) |
| September 24, 2025 | NCT07191366 | Antenatal Breastmilk Expression in Pregnant Women at High Risk of Preterm Birth | Odense University Hospital | Not applicable | Not yet recruiting | Preterm Birth, PPROM, Preeclampsia, Previous Preterm Birth | 250 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07191366) |
| September 24, 2025 | NCT07190846 | Diastolic Dysfunction 2025 | University Tunis El Manar | Observational | Completed | Preeclampsia, Severe Preeclampsia | 80 | Tunisia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07190846) |
| September 23, 2025 | NCT07187596 | Mortality Outcome of Controlled Hypertension | DejthidaNathaphong | Observational | Active not recruiting | Hypertension, Morality, Death, Pre-Eclampsia, Cardiovascular Diseases, Stroke, Renal Disease, Artery Stenosis, Arterial... | 2,547 | Thailand | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07187596) |
| September 22, 2025 | NCT07185204 | Postpartum Preeclampsia Early Detection and Treatment: Nepal Pilot Study | Medical College of Wisconsin | Not applicable | Recruiting | Postpartum Preeclampsia | 60 | Nepal, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07185204) |
| September 19, 2025 | NCT07183384 | MSC Exosome Therapy for Post-Preeclampsia Endothelial Dysfunction | Universitas Padjadjaran | Phase 1/2 | Recruiting | Preeclampsia, Postpartum, Endothelial Injury, Exosome Multiomics, Cell Therapy | 80 | Indonesia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07183384) |
| September 17, 2025 | NCT07178652 | Preeclampsia and Defective Placentation in Oocyte Donation: Importance of HLA-C and KIR | Universitair Ziekenhuis Brussel | Observational | Not yet recruiting | Preeclampsia (PE) Risk, Oocyte Donation | 2,325 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07178652) |
| September 11, 2025 | NCT07167862 | Optimizing Preeclampsia Postpartum With Point-of-care Ultrasound | University of California, Irvine | Phase 4 | Recruiting | Preeclampsia, Preeclampsia Postpartum, Preeclampsia Severe or Mild | 96 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07167862) |
| September 10, 2025 | NCT07164326 | Dexmedetomidine Nebulization for Attenuation of Pressor Response to Laryngoscopy and Endotracheal Intubation in Sever Preeclamptic Patients | Assiut University | Not applicable | Not yet recruiting | Pressor Response | 100 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07164326) |
| September 3, 2025 | NCT07151339 | Pilot Project Renal and Cardiovascular Tertiary Prevention in Preeclampsia | University Hospital Schleswig-Holstein | Observational | Recruiting | Preeclampsia, HELLP Syndrome, Eclampsia, Kidney Disease | 100 | Germany | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07151339) |
| August 15, 2025 | NCT07125599 | The Association Between Different Markers With Development of Maternal and Neonatal Complications in Women With Severe Preeclampsia | Cairo University | Observational | Completed | Severe Preeclampsia | 284 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07125599) |

## Sponsors posting most

| Sponsor | New trials | Latest |
| --- | --- | --- |
| Cairo University | 5 | March 2, 2026 |
| Assiut University | 4 | October 8, 2026 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 4 | December 23, 2025 |
| Istanbul University - Cerrahpasa | 4 | March 27, 2025 |
| Anna Stanhewicz, PhD | 3 | July 20, 2026 |
| University Tunis El Manar | 3 | June 12, 2026 |
| Massachusetts General Hospital | 3 | May 29, 2026 |
| Medical College of Wisconsin | 3 | November 14, 2025 |
| Muhammad Aamir Latif | 2 | October 1, 2026 |
| Benha University | 2 | September 25, 2026 |
| Women and Infants Hospital of Rhode Island | 2 | August 7, 2026 |
| Samsun University | 2 | August 4, 2026 |
| Hospital Universitari Vall d'Hebron Research Institute | 2 | June 24, 2026 |
| University of Tennessee Graduate School of Medicine | 2 | May 4, 2026 |
| University of Oxford | 2 | March 13, 2026 |
| Washington University School of Medicine | 2 | March 11, 2026 |
| Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2 | January 21, 2026 |
| Saint Thomas Hospital, Panama | 2 | December 4, 2025 |
| Heidelberg University | 2 | August 6, 2025 |
| Xiamen Amoytop Biotech Co., Ltd. | 2 | April 11, 2025 |

## By phase

| Phase | New trials | Latest |
| --- | --- | --- |
| [Not applicable](https://specstream.ai/data/clinical-trials/phase/not-applicable) | 62 | November 3, 2026 |
| [Observational](https://specstream.ai/data/clinical-trials/phase/observational) | 61 | October 26, 2026 |
| [Phase 4](https://specstream.ai/data/clinical-trials/phase/phase-4) | 12 | August 31, 2026 |
| [Phase 3](https://specstream.ai/data/clinical-trials/phase/phase-3) | 5 | August 5, 2026 |
| [Phase 1](https://specstream.ai/data/clinical-trials/phase/phase-1) | 5 | January 8, 2026 |
| [Early phase 1](https://specstream.ai/data/clinical-trials/phase/early-phase-1) | 4 | July 20, 2026 |
| [Phase 2](https://specstream.ai/data/clinical-trials/phase/phase-2) | 4 | June 15, 2026 |
| [Phase 1/2](https://specstream.ai/data/clinical-trials/phase/phase-1-2) | 3 | July 31, 2026 |

## By country

| Country | New trials | Latest |
| --- | --- | --- |
| [United States](https://specstream.ai/data/clinical-trials/country/united-states) | 34 | October 26, 2026 |
| [Turkey (Türkiye)](https://specstream.ai/data/clinical-trials/country/turkey-t-rkiye) | 14 | October 14, 2026 |
| [Egypt](https://specstream.ai/data/clinical-trials/country/egypt) | 13 | September 25, 2026 |
| [Spain](https://specstream.ai/data/clinical-trials/country/spain) | 10 | June 24, 2026 |
| [Pakistan](https://specstream.ai/data/clinical-trials/country/pakistan) | 9 | November 3, 2026 |
| [China](https://specstream.ai/data/clinical-trials/country/china) | 6 | February 3, 2026 |
| [Italy](https://specstream.ai/data/clinical-trials/country/italy) | 4 | September 25, 2026 |
| [France](https://specstream.ai/data/clinical-trials/country/france) | 4 | September 17, 2026 |
| [United Kingdom](https://specstream.ai/data/clinical-trials/country/united-kingdom) | 3 | June 24, 2026 |
| [Tunisia](https://specstream.ai/data/clinical-trials/country/tunisia) | 3 | June 12, 2026 |
| [Denmark](https://specstream.ai/data/clinical-trials/country/denmark) | 3 | March 20, 2026 |
| [Germany](https://specstream.ai/data/clinical-trials/country/germany) | 3 | September 3, 2025 |
| [Israel](https://specstream.ai/data/clinical-trials/country/israel) | 2 | July 31, 2026 |
| [Austria](https://specstream.ai/data/clinical-trials/country/austria) | 2 | June 24, 2026 |
| [Bulgaria](https://specstream.ai/data/clinical-trials/country/bulgaria) | 2 | June 24, 2026 |
| [Hong Kong](https://specstream.ai/data/clinical-trials/country/hong-kong) | 2 | June 4, 2026 |
| [Czechia](https://specstream.ai/data/clinical-trials/country/czechia) | 2 | June 2, 2026 |
| [Nigeria](https://specstream.ai/data/clinical-trials/country/nigeria) | 2 | March 11, 2026 |
| [Greece](https://specstream.ai/data/clinical-trials/country/greece) | 2 | January 23, 2026 |
| [Panama](https://specstream.ai/data/clinical-trials/country/panama) | 2 | December 4, 2025 |
| [Sweden](https://specstream.ai/data/clinical-trials/country/sweden) | 2 | September 30, 2025 |
| [Uganda](https://specstream.ai/data/clinical-trials/country/uganda) | 1 | September 28, 2026 |
| Zimbabwe | 1 | September 9, 2026 |
| [Croatia](https://specstream.ai/data/clinical-trials/country/croatia) | 1 | July 27, 2026 |
| [Ghana](https://specstream.ai/data/clinical-trials/country/ghana) | 1 | June 24, 2026 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it.

Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).